| ANAEROPHARMA SCIENCE, INC. Patent applications |
| Patent application number | Title | Published |
|---|
| 20130122582 | EXPRESSION VECTOR - A conventional shuttle vector constructed by fusing an | 05-16-2013 |
| 20130095072 | THERAPEUTIC AGENT FOR ISCHEMIC DISEASES | 04-18-2013 |
| 20110190472 | TRANSFECTION VECTOR - The present invention relates to a novel secretory signal, a novel plasmid containing the secretory signal, a transformed anaerobic bacterium transformed with said plasmid, a gene transfer carrier consisting of said anaerobic bacterium, and a pharmaceutical composition containing said carrier. | 08-04-2011 |
| 20110189758 | TRANSFECTION VECTOR - The present invention relates to a novel secretory signal, a novel plasmid containing the secretory signal, a transformed anaerobic bacterium transformed with said plasmid, a gene transfer carrier consisting of said anaerobic bacterium, and a pharmaceutical composition containing said carrier. | 08-04-2011 |
| 20110189757 | TRANSFECTION VECTOR - The present invention relates to a novel secretory signal, a novel plasmid containing the secretory signal, a transformed anaerobic bacterium transformed with said plasmid, a gene transfer carrier consisting of said anaerobic bacterium, and a pharmaceutical composition containing said carrier. | 08-04-2011 |
| 20110110893 | THERAPEUTIC AGENT FOR ANAEROBIC DISEASES - The present invention provides a therapeutic agent for anaerobic diseases such as solid tumor, comprising in combination a pharmaceutical composition for the treatment of an anaerobic disease containing the transformed anaerobic microorganism as an active component and a pharmaceutical composition containing as an active component an anaerobic microorganism colonization and growth enhancer for enhancing the specific colonization and proliferation of the anaerobic microorganism at an anaerobic disease site. Furthermore, the present invention provides to an anaerobic microorganism colonization and growth enhancer for enhancing colonization and growth of the transformed anaerobic microorganism at a disease site that is in an anaerobic environment. | 05-12-2011 |
